Aug 5 (Reuters) - Cadrenal Therapeutics Inc CVKD.O:
CADRENAL THERAPEUTICS ANNOUNCES CLINICAL TRIAL INITIATION PLANS FOR TECARFARIN IN PATIENTS WITH END-STAGE KIDNEY DISEASE (ESKD) TRANSITIONING TO DIALYSIS
CADRENAL THERAPEUTICS INC - ENROLLMENT FOR TECARFARIN TRIAL TO BEGIN LATER THIS YEAR